SCHEMBL23965123

SCHEMBL23965123

CC1(C)OB(c2nc(-c3ccccc3)nc(-c3ccc4ccccc4c3)n2)OC1(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 2/20 0.57
LIPG Q9Y5X9 2/20 0.57
ALDH1A1 P00352 4/20 0.46
CYP1A2 P05177 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 2/20 0.46
TP53 P04637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.38
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
HPGD P15428 3/20 0.36
MAPT P10636 2/20 0.36
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26272405 0.99 LIPG (0.59) LPLLIPGALDH1A1CYP1A2SMN1; SMN2
SCHEMBL23965291 0.96 LIPG (0.63) LPLLIPGALDH1A1CYP1A2SMN1; SMN2
SCHEMBL23965397 0.96 LPL (0.61) LPLLIPGALDH1A1CYP1A2SMN1; SMN2
SCHEMBL23965040 0.90 LPL (0.46) LPLLIPGALDH1A1CYP1A2SMN1; SMN2
SCHEMBL19106578 0.89 LIPG (0.74) LPLLIPGALDH1A1CYP1A2SMN1; SMN2
SCHEMBL22117456 0.88 LIPG (0.59) LPLLIPGALDH1A1SMN1; SMN2MEN1
SCHEMBL23327890 0.88 LIPG (0.59) LPLLIPGALDH1A1SMN1; SMN2MEN1
SCHEMBL15803154 0.88 LPL (0.53) LPLLIPGALDH1A1SMN1; SMN2MEN1
SCHEMBL31643264 0.87 LPL (0.52) LPLLIPGALDH1A1CYP1A2SMN1; SMN2
SCHEMBL23105621 0.87 LPL (0.52) LPLLIPGALDH1A1CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-21 US disclosed
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-21 US disclosed
US-20230183191-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-15 US disclosed
US-20230183191-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-15 US disclosed
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301182-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME OR10J3, ESR1, EPCAM LPL 1889/4885LIPG 712/4885ALDH1A1 496/4885
US-20230183191-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE CNOT1, NXF1, NR2E1 LPL 4496/4885LIPG 3859/4885ALDH1A1 2636/4885
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNL2, MCM6, CRY1 LPL 2546/4885LIPG 3610/4885ALDH1A1 2007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.